The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals

Strawbridge RJ, Johnston KJA, Bailey MES, Baldassarre D, Cullen B, Eriksson P, deFaire U, Ferguson A, Gigante B, Giral P, Graham N, Hamsten A, Humphries SE, Kurl S, Lyall DM, Lyall LM, Pell JP, Pirro M, Savonen K, Smit AJ, Tremoli E, Tomainen TP, Veglia F, Ward J, Sennblad B, Smith DJ

Sci Rep 11 (1) - [2021-12-00; online 2021-01-12]

NGI Uppsala (SNP&SEQ Technology Platform)

National Genomics Infrastructure [Service]

QC bibliography QC xrefs

DOI 10.1038/s41598-020-79964-x

Crossref 10.1038/s41598-020-79964-x